The International Tennis Integrity Agency (ITIA) has confirmed that Simona Halep, a 31-year-old Romanian tennis player, has been provisionally suspended under Article 7.12.1 of the 2022 Tennis Anti-Doping Programme (TADP). The ITIA sent the player a pre-charge notice of an Anti-Doping Rule Violation on 7 October 2022 under Article 2.1 of the Programme (presence of a Prohibited Substance in a Player’s Sample) and/or Article 2.2 (Use of a Prohibited Substance without a valid TUE).
Halep, who has a WTA ranking of 9, provided a sample whilst competing at the US Open in August 2022. The sample was split into A and B samples and the subsequent analysis found that the A sample contained FG-4592 (Roxadustat), which is a prohibited substance listed in the 2022 World Anti-Doping Agency (WADA) Prohibited List. Adverse Analytical Findings for non-specified substances carry a mandatory provisional suspension.
The player exercised their right to request that the B sample was analysed, which confirmed the finding in the A sample. While provisionally suspended, the player is ineligible to compete in or attend any sanctioned tennis events organised by the governing bodies of the sport.
The ITIA is the delegated third party, under the World Anti-Doping Code of the International Tennis Federation, the international governing body for the sport of tennis and signatory of the Code. The ITIA is responsible for the management and administration of anti-doping across professional tennis in accordance with the 2022 TADP.
Ends
Published 21 October 2022 14:30
